MedTrace Logo

Psychotherapy for Patients With Psoriasis: Effects in Quality of Life

NCT02944630 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2016-10-26

No results posted yet for this study

Summary

The aim of this study is to determine the benefits of individual psychotherapy on quality of life for people with psoriasis receiving medical treatment versus a control group (awaiting group) treated with medical treatment, without psychotherapy.

Conditions

Interventions

BEHAVIORAL

Psychotherapy

Individual psychotherapy

Sponsors & Collaborators

  • Universitat Autonoma de Barcelona

    collaborator OTHER

  • Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau

    lead OTHER

Principal Investigators

  • Esther Margarit de Miguel, Msc · Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau

  • Antoni Font Guiteras, PhD · Universitat Autonoma de Barcelona

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-10-31
Primary Completion
2019-01-31
Completion
2020-01-31

Countries

  • Spain

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02944630 on ClinicalTrials.gov